10-6035833-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000417.3(IL2RA):c.65-9808A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.714 in 152,212 control chromosomes in the GnomAD database, including 39,546 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.71 ( 39534 hom., cov: 32)
Exomes 𝑓: 0.64 ( 12 hom. )
Consequence
IL2RA
NM_000417.3 intron
NM_000417.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.02
Publications
20 publications found
Genes affected
IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]
IL2RA Gene-Disease associations (from GenCC):
- immunodeficiency due to CD25 deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- neonatal diabetes mellitusInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- neonatal diabetes mellitus with congenital hypothyroidismInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- type 1 diabetes mellitus 10Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.905 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IL2RA | NM_000417.3 | c.65-9808A>G | intron_variant | Intron 1 of 7 | ENST00000379959.8 | NP_000408.1 | ||
| IL2RA-AS1 | XR_001747349.2 | n.424T>C | non_coding_transcript_exon_variant | Exon 1 of 2 | ||||
| IL2RA | NM_001308242.2 | c.65-9808A>G | intron_variant | Intron 1 of 6 | NP_001295171.1 | |||
| IL2RA | NM_001308243.2 | c.65-9808A>G | intron_variant | Intron 1 of 5 | NP_001295172.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.714 AC: 108593AN: 152036Hom.: 39487 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
108593
AN:
152036
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.643 AC: 36AN: 56Hom.: 12 AF XY: 0.682 AC XY: 30AN XY: 44 show subpopulations
GnomAD4 exome
AF:
AC:
36
AN:
56
Hom.:
AF XY:
AC XY:
30
AN XY:
44
show subpopulations
African (AFR)
AF:
AC:
2
AN:
2
American (AMR)
AF:
AC:
1
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
2
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
26
AN:
40
Other (OTH)
AF:
AC:
5
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.714 AC: 108697AN: 152156Hom.: 39534 Cov.: 32 AF XY: 0.715 AC XY: 53197AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
108697
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
53197
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
34361
AN:
41510
American (AMR)
AF:
AC:
9300
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
2192
AN:
3466
East Asian (EAS)
AF:
AC:
4802
AN:
5182
South Asian (SAS)
AF:
AC:
3910
AN:
4824
European-Finnish (FIN)
AF:
AC:
6957
AN:
10576
Middle Eastern (MID)
AF:
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
AC:
44898
AN:
67996
Other (OTH)
AF:
AC:
1441
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1547
3094
4641
6188
7735
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2971
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.